Vaidya Sane Ayurved Laboratories Ltd.

•

madhavbaug.orgBSE: -NSE: MADHAVBAUG

Market Cap₹ 169 Cr.

Current Price

High / Low₹ 335 / 150

Stock P/E34.2

Book Value₹ 57

Price to Book1.65

Dividend Yield0.00 %

ROCE12.0 %

ROE9.7 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2025 • Sale of Product Activity: 64.4% • Hospital Activity: 26.6% • Common / Unallocable: 8.9%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 0.95x)
Company comfortably covers its interest (33.2x coverage)
Company generates healthy free cash flow

CONS

Receivables are growing faster than sales - a possible quality concern
Company has a low return on equity of 8.6% over last 3 years
A large part of profit comes from other income (25.8% of PBT)
Company has a low return on capital employed of 11.8%
Company has delivered a poor sales growth of 3.0% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	APOLLOHOSP	8784.00	60.45	126300.44	0.23	610.40	38.41	7043.50	20.56	21.73	15.70
2.	MAXHEALTH	994.20	66.42	96763.15	0.20	322.96	4.87	2366.17	16.70	14.97	25.29
3.	MANIPALHOS	726.00	107.02	95496.38	0.00	2434.30	—	30906.30	—	13.93	23.83
4.	FORTIS	912.65	65.75	68901.26	0.11	272.80	2.26	2545.03	17.46	14.07	21.28
5.	ASTERDM	786.90	215.24	68591.90	0.00	29.28	-68.70	1310.68	21.60	11.46	19.53
6.	NH	1880.95	47.10	38439.25	0.24	207.27	5.37	2683.63	78.05	16.20	17.43
7.	MEDANTA	1418.85	68.59	38148.87	0.04	157.25	-1.09	1304.05	26.50	19.38	21.99
8.	LALPATHLAB	1921.90	59.53	32258.86	1.07	1705.00	1172.39	7977.00	1090.95	29.56	31.03
9.	KIMS	767.40	157.76	32231.30	0.00	37.40	-56.00	1179.50	35.33	11.51	19.03
10.	AGARWALEYE	512.55	109.52	16249.18	0.00	55.02	44.56	614.02	25.97	16.14	27.75
11.	VIJAYA	1505.95	82.73	15510.94	0.13	53.10	37.61	230.98	22.83	30.28	42.66
12.	MADHAVBAUG	160.30	18.75	168.53	0.00	—	—	—	—	16.70	—

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

No standalone quarterly results found

We don't have this information yet. Please check back later.

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	62	75	52	75	99	97	87
	59	72	49	67	90	94	77
Operating Profit	3	3	3	7	9	3	10
OPM %	4.96%	3.86%	6.32%	9.80%	9.09%	3.26%	11.76%
	0	0	0	0	1	2	1
Interest	1	1	1	1	1	0	0
Depreciation	2	2	2	2	3	3	4
Profit before Tax	1	-0	0	5	7	1	7
Tax %	43.75%	-24.63%	13.81%	26.95%	24.90%	28.05%	28.70%
Net Profit	0	-1	0	3	5	1	5
EPS	110.20	-123.82	87.11	8.00	4.94	0.99	4.66
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	5.06%	0.00%	0.00%

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 3%
3 Years:: 5%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: 12%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: -15%
1 Year:: 42%

RETURN ON EQUITY

10 Years:: —
5 Years:: 9%
3 Years:: 9%
Last Year:: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0	0	0	11	11	11	11
	9	8	10	25	30	31	49
	9	6	1	1	0	3	3
Trade Payables	6	8	7	7	9	9	7
	5	7	8	6	5	18	4
Total Liabilities	29	29	26	50	55	71	74
	16	16	17	17	21	22	27
Capital Work in Progress	2	4	0	1	2	1	0
	0	0	0	21	15	25	26
	4	3	2	2	3	3	2
	0	0	0	0	0	6	7
Cash & Bank	1	1	1	3	2	2	2
	7	6	6	6	13	11	9
Total Assets	29	29	26	50	55	71	74

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	2	8	6	-12	2	3	8
Cash from Investing	-10	-4	-1	-8	1	-17	-7
Cash from Financing	8	-4	-5	22	-1	14	-1
	-1	0	-0	2	-1	0	0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	110.20	-123.82	87.11	3.30	4.94	0.99	4.66
Book Value (₹)	1951.11	1826.64	2170.44	34.13	38.82	39.56	56.78
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.25	0.00	0.00
Cash EPS (₹)	2.99	2.39	4.07	5.47	7.41	3.87	8.20
PROFITABILITY
Operating Margin %	5.07%	3.95%	6.52%	10.26%	10.47%	3.26%	11.76%
Net Margin %	0.79%	-0.74%	0.75%	4.64%	5.24%	1.07%	5.62%
ROE %	5.65%	-6.56%	4.36%	15.20%	13.53%	2.54%	9.67%
ROCE %	9.04%	4.73%	7.69%	22.53%	19.94%	3.50%	12.02%
	1.72%	-1.92%	1.43%	9.16%	9.86%	1.66%	6.77%
EFFICIENCY
Debtor Days	21	15	18	15	18	23	27
Inventory Days	21	16	16	8	9	12	11
Payable Days	138	124	162	117	108	115	122
	-95	-94	-128	-94	-80	-80	-85
FINANCIAL HEALTH
Debt to Equity (x)	0.99x	0.73x	0.10x	0.03x	0.00x	0.04x	0.02x
Interest Coverage (x)	2.27x	0.63x	1.90x	8.57x	9.08x	6.70x	33.24x
	0.53x	0.45x	0.52x	2.04x	2.24x	2.27x	2.29x
GROWTH
Revenue Growth %	0.00%	20.38%	-30.51%	42.92%	32.55%	-1.71%	-10.50%
Operating Profit Growth %	0.00%	-6.15%	14.55%	124.86%	35.25%	-54.32%	153.75%
Net Profit Growth %	0.00%	-212.36%	170.35%	784.95%	49.61%	-79.87%	368.58%
	0.00%	0.00%	0.00%	0.00%	0.00%	-79.86%	368.56%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	175.05x	20.12x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	4.40x	1.65x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	0.00x	0.00x	38.54x	8.13x

Shareholding Pattern

Numbers in percentages

	Sep 2023	Dec 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Dec 2025	Mar 2026
	66.34	66.34	66.34	66.34	66.34	66.34	66.34	66.34
FIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	0.00	0.00	0.00	0.00	0.00	0.21	0.00	0.00
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	33.66	33.66	33.66	33.66	33.66	33.45	33.66	33.66

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for MADHAVBAUG

Loading news…

🤖

AI Stock Analyst

Vaidya Sane Ayurved Laboratories Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

APOLLOHOSP

8784.00

60.45

126300.44

0.23

610.40

38.41

7043.50

20.56

21.73

15.70

MAXHEALTH

994.20

66.42

96763.15

0.20

322.96

4.87

2366.17

16.70

14.97

25.29

MANIPALHOS

726.00

107.02

95496.38

0.00

2434.30

—

30906.30

—

13.93

23.83

FORTIS

912.65

65.75

68901.26

0.11

272.80

2.26

2545.03

17.46

14.07

21.28

ASTERDM

786.90

215.24

68591.90

0.00

29.28

-68.70

1310.68

21.60

11.46

19.53

1880.95

47.10

38439.25

0.24

207.27

5.37

2683.63

78.05

16.20

17.43

MEDANTA

1418.85

68.59

38148.87

0.04

157.25

-1.09

1304.05

26.50

19.38

21.99

LALPATHLAB

1921.90

59.53

32258.86

1.07

1705.00

1172.39

7977.00

1090.95

29.56

31.03

KIMS

767.40

157.76

32231.30

0.00

37.40

-56.00

1179.50

35.33

11.51

19.03

AGARWALEYE

512.55

109.52

16249.18

0.00

55.02

44.56

614.02

25.97

16.14

27.75

VIJAYA

1505.95

82.73

15510.94

0.13

53.10

37.61

230.98

22.83

30.28

42.66

MADHAVBAUG

160.30

18.75

168.53

0.00

—

16.70

—

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Operating Profit

OPM %

4.96%

3.86%

6.32%

9.80%

9.09%

3.26%

11.76%

Interest

Depreciation

Profit before Tax

-0

Tax %

43.75%

-24.63%

13.81%

26.95%

24.90%

28.05%

28.70%

Net Profit

-1

EPS

110.20

-123.82

87.11

8.00

4.94

0.99

4.66

Dividend Payout %

0.00%

5.06%

0.00%

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Equity Capital

Trade Payables

Total Liabilities

Capital Work in Progress

Cash & Bank

Total Assets

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

-12

Cash from Investing

-10

-4

-1

-8

-17

-7

Cash from Financing

-4

-5

-1

-0

-1

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

110.20

-123.82

87.11

3.30

4.94

0.99

4.66

Book Value (₹)

1951.11

1826.64

2170.44

34.13

38.82

39.56

56.78

Dividend per Share (₹)

0.00

0.25

0.00

Cash EPS (₹)

2.99

2.39

4.07

5.47

7.41

3.87

8.20

PROFITABILITY

Operating Margin %

5.07%

3.95%

6.52%

10.26%

10.47%

3.26%

11.76%

Net Margin %

0.79%

-0.74%

0.75%

4.64%

5.24%

1.07%

5.62%

ROE %

5.65%

-6.56%

4.36%

15.20%

13.53%

2.54%

9.67%

ROCE %

9.04%

4.73%

7.69%

22.53%

19.94%

3.50%

12.02%

1.72%

-1.92%

1.43%

9.16%

9.86%

1.66%

6.77%

EFFICIENCY

Debtor Days

Inventory Days

Payable Days

138

124

162

117

108

115

122

-95

-94

-128

-94

-80

-85

FINANCIAL HEALTH

Debt to Equity (x)

0.99x

0.73x

0.10x

0.03x

0.00x

0.04x

0.02x

Interest Coverage (x)

2.27x

0.63x

1.90x

8.57x

9.08x

6.70x

33.24x

0.53x

0.45x

0.52x

2.04x

2.24x

2.27x

2.29x

GROWTH

Revenue Growth %

0.00%

20.38%

-30.51%

42.92%

32.55%

-1.71%

-10.50%

Operating Profit Growth %

0.00%

-6.15%

14.55%

124.86%

35.25%

-54.32%

153.75%

Net Profit Growth %

0.00%

-212.36%

170.35%

784.95%

49.61%

-79.87%

368.58%

0.00%

-79.86%

368.56%

VALUATION

P/E (x)

0.00x

175.05x

20.12x

P/B (x)

0.00x

4.40x

1.65x

Dividend Yield %

0.00%

0.00x

38.54x

8.13x

Sep 2023

Dec 2023

Mar 2024

Sep 2024

Mar 2025

Sep 2025

Dec 2025

Mar 2026

66.34

FIIs

0.00

0.21

0.00

Government

0.00

33.66

33.45

33.66

Vaidya Sane Ayurved Laboratories Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Vaidya Sane Ayurved Laboratories Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI